The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The percutaneous nephrolithotomy (PCNL) market has experienced robust growth, expanding from $16.49 billion in 2023 to an anticipated $17.90 billion in 2024, with a compound annual growth rate (CAGR) of 8.6%.

• Market Growth Drivers:
  • Increasing prevalence of kidney stones.
  • Rising demand for efficient kidney stone treatments.
  • Expansion of healthcare infrastructure in emerging economies.
  • Aging population leading to a higher incidence of kidney stones.
  • Surge in research and development activities.
  • Growing healthcare expenditure.
  • Emphasis on patient-centric healthcare.

Future Projections: Continued Expansion
The market is projected to continue its upward trajectory, reaching $25.15 billion by 2028, with a CAGR of 8.9%.

• Key Growth Factors:
  • Adoption of minimally invasive surgical procedures.
  • Rising demand for effective stone removal techniques.
  • Increasing awareness of the benefits of PCNL.
  • Growing geriatric population prone to kidney stones.
  • Availability of advanced medical technologies for stone removal.
  • Focus on patient-centric care.
  • Preference for outpatient procedures.

View More On The Percutaneous Nephrolithotomy Market Report 2024 – https://www.thebusinessresearchcompany.com/report/percutaneous-nephrolithotomy-global-market-report

Impact of Rising Renal Disease Prevalence
The increasing prevalence of renal diseases is a significant driver of the PCNL market.

• Contributing Factors:
  • Rising rates of diabetes and hypertension.
  • Aging population and poor lifestyle choices.
  • Genetic predisposition and chronic conditions.
  • Improved awareness and diagnosis of renal diseases.
• PCNL’s Role in Renal Disease Management:
  • Minimally invasive surgical removal of large or complex kidney stones.
  • Alleviation of pain and prevention of urinary tract infections.
  • Improvement of kidney function.

Advancements in Robot-Assisted Surgical Platforms
Innovations in robot-assisted surgical platforms are propelling the PCNL market forward.

• Technological Innovations:
  • Enhanced precision, control, and flexibility in surgical procedures.
  • Improved navigation, access, clearance, and control compared to traditional methods.
• Example:
  • In February 2023, Ethicon Inc. successfully performed robotic-assisted kidney stone removal using the MONARCH Platform, offering significant advantages in PCNL procedures.

Strategic Acquisitions Bolstering Market Position
Major companies are pursuing strategic acquisitions to strengthen their market presence.

• Notable Acquisition:
  • In March 2021, Boston Scientific acquired Lumenis Ltd., integrating Lumenis’ MOSES technology to enhance clinical outcomes in kidney stone management, particularly in PCNL procedures.

Segmentation and Regional Insights
The PCNL market is segmented by stone type, component, and end-user, with North America leading the market in 2023.

• Market Segmentation:
  • By Type: Magnesium Ammonium Phosphate Stone Type, Calcareous Type, Uric Acid Calculi Type.
  • By Component: Accessories, Devices, Services.
  • By End-User: Ambulatory Surgical Centers, Clinics, Hospitals.
• Regional Coverage:
  • Asia-Pacific, Western Europe, and Eastern Europe are also key regions driving market growth.

Request A Sample Of The Global Percutaneous Nephrolithotomy Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16506&type=smp